RA
IBB icon

Rockingstone Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Rockingstone Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$606K Buy
3,185
+100
+3% +$17.2K 0.24% 79
2026
Q1 		$521K Hold
3,085
– – 0.24% 84
2025
Q4 		$521K Sell
3,085
-243
-7% -$39.5K 0.24% 83
2025
Q3 		$480K Sell
3,328
-710
-18% -$96.9K 0.24% 80
2025
Q2 		$511K Sell
4,038
-285
-7% -$35K 0.27% 80
2025
Q1 		$553K Sell
4,323
-1,740
-29% -$236K 0.25% 80
2024
Q4 		$802K Sell
6,063
-2,217
-27% -$312K 0.35% 68
2024
Q3 		$1.21M Buy
8,280
+20
+0.2% +$2.89K 0.59% 52
2024
Q2 		$1.13M Sell
8,260
-50
-0.6% -$6.67K 0.58% 54
2024
Q1 		$1.14M Sell
8,310
-85
-1% -$11.6K 0.59% 61
2023
Q4 		$1.14M Buy
8,395
+555
+7% +$67.7K 0.64% 57
2023
Q3 		$959K Buy
7,840
+589
+8% +$74.9K 0.53% 59
2023
Q2 		$921K Hold
7,251
– – 0.52% 61
2023
Q1 		$937K Sell
7,251
-518
-7% -$67.8K 0.57% 61
2022
Q4 		$1.02M Buy
+7,769
New +$1M 0.76% 55

Other funds holding IBB

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return

Rockingstone Advisors's IBB Position: Q2 2026 in Review

Rockingstone Advisors increased its iShares Biotechnology ETF (IBB) stake by 3.2% in Q2 2026, buying an estimated $17.2K and bringing the position to 3,185 shares worth $606K. The position accounts for 0.24% of the portfolio, ranked #79.

Rockingstone Advisors first reported a position in IBB in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.21M in Q3 2024. 421 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Rockingstone Advisors held 3,185 shares of iShares Biotechnology ETF worth $606K as of Q2 2026.
  • Rockingstone Advisors bought 100 iShares Biotechnology ETF shares in Q2 2026, an estimated $17.2K.
  • iShares Biotechnology ETF made up 0.24% of Rockingstone Advisors's portfolio in Q2 2026, its #79 holding.
  • Rockingstone Advisors first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 15 quarters since.
  • Rockingstone Advisors's iShares Biotechnology ETF position peaked at $1.21M in Q3 2024.
  • 421 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Rockingstone Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.